Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lactulose.

Literature DB >> 4929274

Lactulose.

S G Elkington.

Abstract

Entities: Chemical

Mesh：

Substances：
Disaccharides

Year: 1970 PMID： 4929274 PMCID： PMC1553161 DOI： 10.1136/gut.11.12.1043

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

31 in total

1. The role of pH gradient in the distribution of ammonia between blood and cerebrospinal fluid, brain and muscle.

Authors: J R STABENAU; K S WARREN; D P RALL
Journal: J Clin Invest Date: 1959-02 Impact factor: 14.808

2. The gastric secretion of drugs: a pH partition hypothesis.

Authors: P A SHORE; B B BRODIE; C A HOGBEN
Journal: J Pharmacol Exp Ther Date: 1957-03 Impact factor: 4.030

3. [The Lactobacillus bifidus factor].

Authors: F PETUELY
Journal: Dtsch Med Wochenschr Date: 1957-11-15 Impact factor: 0.628

4. Neomycin in the treatment of hepatic coma.

Authors: A M DAWSON; J McLAREN; S SHERLOCK
Journal: Lancet Date: 1957-12-21 Impact factor: 79.321

5. Treatment of chronic hepatic encephalopathy.

Authors:
Journal: Lancet Date: 1970-08-29 Impact factor: 79.321

6. Treatment of chronic constipation with lactulose syrup: results of a double-blind study.

Authors: A Wesselius-De Casparis; S Braadbaart; G E Bergh-Bohlken; M Mimica
Journal: Gut Date: 1968-02 Impact factor: 23.059

7. [Treatment of chronic hepatic coma with lactulose].

Authors: J Bircher
Journal: Ther Umsch Date: 1969-05

8. Treatment of chronic portal-systemic encephalopathy by surgical exclusion of the colon.

Authors: J G Walker; A Emlyn-Williams; V M Rosenoer; A Craigie; J Agnew
Journal: Lancet Date: 1965-10-30 Impact factor: 79.321

9. Intestinal lactase deficiency and saccharide malabsorption during oral neomycin administration.

Authors: I C Paes; P Searl; M W Rubert; W W Faloon
Journal: Gastroenterology Date: 1967-07 Impact factor: 22.682

10. Ammonia in the upper gastrointestinal tract of man: quantitations and relationships.

Authors: W H Summerskill; T Aoyagi; W B Evans
Journal: Gut Date: 1966-10 Impact factor: 23.059

17 in total

1. L-Ornithine L-Aspartate is Effective and Safe for the Treatment of Hepatic Encephalopathy in Cirrhosis.

Authors: Sandeep S Sidhu
Journal: J Clin Exp Hepatol Date: 2018-09-05

2. Lactulose-induced pneumatosis intestinalis and pneumoperitoneum.

Authors: R A Goodman; T R Riley
Journal: Dig Dis Sci Date: 2001-11 Impact factor: 3.199

Review 3. Diarrhoea: mechanisms and treatment.

Authors: T S Low-Beer; A E Read
Journal: Gut Date: 1971-12 Impact factor: 23.059

Lactulose.

1. The role of pH gradient in the distribution of ammonia between blood and cerebrospinal fluid, brain and muscle.

2. The gastric secretion of drugs: a pH partition hypothesis.

3. [The Lactobacillus bifidus factor].

4. Neomycin in the treatment of hepatic coma.

5. Treatment of chronic hepatic encephalopathy.

6. Treatment of chronic constipation with lactulose syrup: results of a double-blind study.

7. [Treatment of chronic hepatic coma with lactulose].

8. Treatment of chronic portal-systemic encephalopathy by surgical exclusion of the colon.

9. Intestinal lactase deficiency and saccharide malabsorption during oral neomycin administration.

10. Ammonia in the upper gastrointestinal tract of man: quantitations and relationships.

1. L-Ornithine L-Aspartate is Effective and Safe for the Treatment of Hepatic Encephalopathy in Cirrhosis.

2. Lactulose-induced pneumatosis intestinalis and pneumoperitoneum.

Review 3. Diarrhoea: mechanisms and treatment.

4. Laxative abuse.

5. Effects of chronic purgative abuse.

Review 6. Laxatives: clinical pharmacology and rational use.

7. Constipation and catharsis.

8. Lactulose-induced pneumatosis intestinalis following colonoscopy: a case report.

9. Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

Review 10. Adverse effects of drugs used in the management of constipation and diarrhoea.